Global Respiratory Inhaler Devices Market Projected to Hit $51.9 Billion by 2034 The respiratory inhaler devices market is set to grow to $51.9 billion by 2034, driven by rising respiratory disease prevalence and tech innovations.

Global Respiratory Inhaler Devices Market Projected to Hit $51.9 Billion by 2034 #USA #Wilmington #COPD_Treatment #Inhaler_Devices #Asthma_Management

Altesa BioSciences Unleashes New Hope for COPD at ERS 2025 Congress Altesa BioSciences unveils promising new treatment for COPD at the ERS 2025. Vapendavir shows significant benefits in symptoms, offering hope to many.

Altesa BioSciences Unleashes New Hope for COPD at ERS 2025 Congress #United_States #Atlanta #Altesa_BioSciences #Vapendavir #COPD_Treatment